文献速递遗传性与小管间质肾病慢性肾脏病血液净化与透析

靶向肾脏炎症:原发性高草酸尿症的新治疗策略?

Targeting kidney inflammation as a new therapy for primary hyperoxaluria?
PubMed 文献 · Nephrol Dial Transplant · 2019-01-01

原发性高草酸尿症(PH)是肝内乙醛酸代谢先天缺陷致内源性草酸过多、尿草酸排泄增高的疾病,草酸钙晶体持续沉积导致肾功能进行性下降。动物模型显示草酸钙晶体结合肾小管细胞,激活肾树突状细胞和巨噬细胞中NALP3依赖的炎症小体,促进纤维化。本文综述PH发病机制,并提出靶向NLRP3炎症小体作为补充治疗策略的可能性。

要点

  • PH由肝内乙醛酸代谢先天缺陷致内源性草酸过多,尿草酸排泄增高。
  • 草酸钙晶体沉积激活NALP3炎症小体,促纤维化并进行性损害肾功能。
  • 靶向NLRP3炎症小体可能成为PH的补充治疗策略。

核心结论

  • 靶向肾脏炎症反应,特别是NLRP3依赖的炎症小体,可能成为治疗原发性高草酸尿症的新补充策略。

研究设计与样本

  • 综述:总结PH发病机制及内源性草酸过多动物模型中草酸钙介导炎症反应的研究证据。

主要发现

  • PH Type 1(AGXT突变)最常见且最严重,患者通常进展至终末期肾病(ESRD)。
  • PH Type 2(GRHPR突变)中20%患者发生ESRD;PH Type 3(HOGA1突变)迄今仅报道1例ESRD。
  • 在草酸富集饲料动物模型中,草酸钙晶体结合肾小管细胞,激活肾树突状细胞和巨噬细胞中NALP3依赖炎症小体,促纤维化并进行性损害肾功能。
  • PH Type 1的ESRD患者需频繁维持性(血液)透析,最终须接受肝肾联合移植作为唯一可用的治愈选择。
  • 靶向炎症反应也被建议用于治疗胱氨酸和尿酸盐在其他器官蓄积所致的晶体性肾病。

临床怎么用

  • 关注PH患者肾脏炎症与纤维化机制,评估NLRP3炎症小体作为潜在治疗靶点的价值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The primary hyperoxalurias (PHs) are inborn errors of glyoxylate metabolism characterized by endogenous oxalate overproduction in the liver, and thus elevated urinary oxalate excretion. The urinary calcium-oxalate (CaOx) supersaturation and the continuous renal accumulation of insoluble CaOx crystals yield a progressive decline in renal function that often ends with renal failure. In PH Type 1 (AGXT mutated), the most frequent and severe condition, patients typically progress to end-stage renal disease (ESRD); in PH Type 2 (GRHPR mutated), 20% of patients develop ESRD, while only one patient with PH Type 3 (HOGA1 mutated) has been reported with ESRD so far. Patients with ESRD undergo frequent maintenance (haemo)dialysis treatment, and finally must receive a combined liver-kidney transplantation as the only curative treatment option available in PH Type 1. In experimental models using oxalate-enriched chow, CaOx crystals were bound to renal tubular cells, promoting a pro-inflammatory environment that led to fibrogenesis in the renal parenchyma by activation of a NACHT, LRR and PYD domains-containing protein 3 (NALP3)-dependent inflammasome in renal dendritic cells and macrophages. Chronic fibrogenesis progressively impaired renal function. Targeting the inflammatory response has recently been suggested as a therapeutic strategy to treat not only oxalate-induced crystalline nephropathies, but also those characterized by accumulation of cystine and urate in other organs. Herein, we summarize the pathogenesis of PH, revising the current knowledge of the CaOx-mediated inflammatory response in animal models of endogenous oxalate overproduction. Furthermore, we highlight the possibility of modifying the NLRP3-dependent inflammasome as a new and complementary therapeutic strategy to treat this severe and devastating kidney disease.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Martin-Higueras C, Ludwig-Portugall I, Hoppe B, et al. Targeting kidney inflammation as a new therapy for primary hyperoxaluria? Nephrol Dial Transplant. 2019. PMID: 30169827. doi:10.1093/ndt/gfy239

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。